Literature DB >> 2234107

Autoradiographic study of the rat vas deferens incubated with 3H-noradrenaline.

I Azevedo1, D Moura, U Trendelenburg.   

Abstract

Rat vasa deferentia were incubated with 0.2 mumol/l 3H-noradrenaline for 60 min and then washed out with amine-free solution for 100 min. Autoradiography then revealed a preferential labelling of the varicosities in the immediate vicinity of the surface of the tissue. However, when tissues were obtained from reserpine- and pargyline-pretreated rats (to block vesicular uptake and monoamine oxidase), 3H-noradrenaline was able to penetrate more deeply into the tissue. These differences are in accordance with the view that the autoradiographs reflect the 3H-noradrenaline concentration gradient (within the extracellular space) generated by the neuronal uptake of the 3H-amine; the concentration gradient is steeper (and the heterogeneity of labelling is more pronounced) in tissues with intact vesicular uptake and monoamine oxidase than in tissues in which these mechanisms had been inhibited.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2234107     DOI: 10.1007/bf00166972

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  9 in total

1.  The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.

Authors:  E Schömig; C L Schönfeld; T Halbrügge; K H Graefe; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  Differential distribution in, and release from, sympathetic nerve endings of endogenous noradrenaline and recently incorporated catecholamines.

Authors:  D Moura; I Azevedo; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

3.  Release, metabolism and intraneuronal disposition of exogenous, endogenous and newly synthesized norepinephrine in the rat vas deferens.

Authors:  G Eisenhofer; T G Ropchak; I J Kopin; D S Goldstein
Journal:  J Pharmacol Exp Ther       Date:  1988-04       Impact factor: 4.030

4.  Time-dependent changes in neuronal net uptake of noradrenaline after pretreatment with pargyline and-or reserpine.

Authors:  K H Graefe; H Bönisch; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmakol       Date:  1971

5.  The inhibitory effect of some monovalent cations on the stimulation by Na+ of the neuronal uptake of noradrenaline.

Authors:  B Keller; K H Graefe
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-11       Impact factor: 3.000

6.  The influence of sympathetic innervation on vascular sensitivity to noradrenaline.

Authors:  I S De la Lande; D Frewin; J G Waterson
Journal:  Br J Pharmacol Chemother       Date:  1967-09

7.  Differential labelling of intraneuronal noradrenaline stores with different concentrations of (-)-3H-noradrenaline.

Authors:  J Hughes
Journal:  Br J Pharmacol       Date:  1973-02       Impact factor: 8.739

8.  Simulation of outward transport of neuronal 3H-noradrenaline with the help of a two-compartment model.

Authors:  E Schömig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  Dihydroxyphenylglycol and intraneuronal metabolism of endogenous and exogenous norepinephrine in the rat vas deferens.

Authors:  G Eisenhofer; T G Ropchak; R W Stull; D S Goldstein; H R Keiser; I J Kopin
Journal:  J Pharmacol Exp Ther       Date:  1987-05       Impact factor: 4.030

  9 in total
  10 in total

1.  The heterogeneity of the neuronal distribution of exogenous noradrenaline in the rat vas deferens.

Authors:  E Schömig; C L Schönfeld; T Halbrügge; K H Graefe; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-08       Impact factor: 3.000

2.  The influence of the density of adrenergic innervation on the extracellular steady-state concentration gradient for 3H-noradrenaline.

Authors:  E Schömig; I Azevedo; D Moura; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-05       Impact factor: 3.000

3.  Release of noradrenaline and ATP by electrical stimulation and nicotine in guinea-pig vas deferens.

Authors:  I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-10       Impact factor: 3.000

4.  Homogeneous or heterogeneous distribution of systemically administered adrenaline: organ dependence.

Authors:  F Brandão; M Q Paiva; A Albino-Teixeira; P Serrão; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-04       Impact factor: 3.000

5.  Release and disposition of 3H-noradrenaline in the saphenous vein of neonate and adult dogs.

Authors:  D Moura; M J Vaz-da-Silva; I Azevedo; F Brandão; S Guimarães
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-02       Impact factor: 3.000

6.  The steady-state concentration gradient for 3H-noradrenaline generated by uptake1 in the extracellular space of the rat vas deferens incubated with this amine.

Authors:  E Schömig; U Trendelenburg; I Azevedo; D Moura
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-07       Impact factor: 3.000

7.  A comparative study of the distribution of tritiated and endogenous noradrenaline in the rat vas deferens and in the dog spleen capsule.

Authors:  M Q Paiva; F Brandão; I Azevedo
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-11       Impact factor: 3.000

8.  The sensitivity of adrenergic varicosities to the 3H-noradrenaline-releasing effect of potassium.

Authors:  C L Schönfeld; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-11       Impact factor: 3.000

9.  Neural ATP release and its alpha 2-adrenoceptor-mediated modulation in guinea-pig vas deferens.

Authors:  B Driessen; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1993-10       Impact factor: 3.000

10.  The energy requirements for the basal efflux of 3H-noradrenaline from sympathetically innervated organs.

Authors:  H Russ; E Schömig; U Trendelenburg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-09       Impact factor: 3.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.